The Wall Avenue Journal with the report
The Novavax vaccine, it says, gives key doable benefits over its opponents:
- early information counsel the Novavax shot could also be one of many first proven to stem asymptomatic unfold of the coronavirus
- and likewise probably present longer-lasting safety
Its a 2 shot vaccine. Approval nonetheless seems a few months away.
An fascinating learn however the agency has clearly misplaced first-mover benefit and by the point it will get approval, then into distribution, it would nicely be too late?